Get the app
US › Healthcare

PharmaCyte Biotech Inc (PMCB)

US · Healthcare · Biotechnology

$0.34-4.81%
Last close · 2026-10-16

Latest quarter · ended 2026-07-31

Revenue
$0
Net profit
$-5.1M
EPS
$-0.54

Key statistics

Market cap
$4.3M
Forward P/E
7.0
P/B
0.16
Book value
$2.60
EPS (TTM)
$-2.31
52-week high
$1.51
52-week low
$0.33
50-day MA
$0.49
200-day MA
$0.68
Beta
0.68

Shareholding

Insiders
5.74%
Institutions
7.11%

Largest institutional holders

FundStake
Citadel Advisors Llc2.64%
Geode Capital Management, LLC1.16%
Vanguard Capital Management, LLC0.53%
Susquehanna International Group, LLP0.42%
Renaissance Technologies Corp0.35%
XTX Topco Ltd0.32%
Northern Trust Corp0.30%
Jane Street Group LLC0.28%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for PharmaCyte Biotech Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.